VET.T 52.50 (+0.97 | +1.88%) VET 51.16 (+0.73 | +1.45%) PAR.UN.T 7.02 (-0.07 | -0.99%) PTSRF.O 7.054 (0.000 | 0.00%) YRI.T 10.86 (-0.04 | -0.37%) AUY 10.65 (-0.04 | -0.37%) SLW.T 23.30 (+0.06 | +0.26%) SLW 22.84 (+0.09 | +0.40%) FM.T 16.60 (-0.22 | -1.31%) AEM.T 30.59 (+0.45 | +1.49%) AEM 30.01 (+0.49 | +1.66%) TCM.T 3.18 (+0.01 | +0.32%) TC 3.12 (+0.02 | +0.65%) HBM.T 7.60 (-0.14 | -1.81%) HBM 7.45 (-0.10 | -1.32%) ERF.T 15.75 (+0.06 | +0.38%) ERF 15.45 (+0.08 | +0.52%) PSTI 2.69 (-0.10 | -3.58%) TTH.T 3.65 (0.00 | 0.00%) TTHI 3.570 (+0.063 | +1.80%) CDM.T 13.79 (-0.06 | -0.43%) CDE 13.52 (-0.04 | -0.29%) RME.T 13.77 (-0.02 | -0.15%) RCKXF.O 13.60 (0.00 | 0.00%) TRL.T 0.65 (+0.01 | +1.56%) SSO.T 6.93 (-0.16 | -2.26%) SSRI 6.795 (-0.175 | -2.51%) CG.T 4.05 (-0.13 | -3.11%) MDI.T 7.35 (-0.01 | -0.14%) PML.V 0.27 (0.00 | 0.00%) MDG.T 0.74 (-0.01 | -1.33%) MDCGF.O 0.728 (0.000 | 0.00%) RVM.T 0.79 (+0.01 | +1.28%) RVM 0.779 (+0.015 | +1.96%) AEI.T 0.430 (+0.005 | +1.18%) IMZ.T 2.51 (-0.01 | -0.40%) AHF.T 1.48 (0.00 | 0.00%) CLQ.T 0.59 (0.00 | 0.00%) CLQMF.O 0.594 (0.000 | 0.00%) KUB.V 0.25 (-0.01 | -3.85%) CAK 0.554 (-0.027 | -4.57%) R.T 0.41 (0.00 | 0.00%) ST.T 0.42 (0.00 | 0.00%) PSD.T 3.79 (-0.03 | -0.79%) PLSDF.O 3.70 (-0.01 | -0.27%) MBA.T 0.15 (0.00 | 0.00%) MBAIF.O 0.137 (0.000 | 0.00%) BNC.T 0.34 (+0.02 | +6.25%) FT.T 0.335 (-0.015 | -4.29%) FTMDF.O 0.341 (-0.000 | -0.06%) HDA.V 0.240 (+0.015 | +6.67%) LOT.V 0.135 (0.000 | 0.00%) GIX.T 0.125 (0.000 | 0.00%) GIXEF.O 0.105 (0.000 | 0.00%) TML.T 0.50 (0.00 | 0.00%) EMD.T 0.090 (+0.005 | +5.88%) TCF.V 0.115 (0.000 | 0.00%) NIF.UN.T 5.13 (-0.01 | -0.19%) NGC.V 0.95 (-0.05 | -5.00%) NGPHF.O 0.927 (-0.048 | -4.87%) SNA.V 0.075 (-0.005 | -6.25%) SRW.V 0.075 (0.000 | 0.00%) SLDRF.O 0.070 (0.000 | 0.00%) SWY.T 0.53 (-0.05 | -8.62%) CEG.T 0.095 (0.000 | 0.00%) CEGMF.O 0.089 (-0.006 | -6.00%) NRN.V 0.21 (+0.03 | +16.67%) CRK.T 0.16 (0.00 | 0.00%) CROCF.O 0.165 (-0.007 | -3.79%) AXI.V 0.07 (0.00 | 0.00%) EE.T 0.225 (0.000 | 0.00%) DBL.V 0.040 (-0.005 | -11.11%) GDM.V 0.01 (0.00 | 0.00%) GMX.T 0.370 (-0.005 | -1.33%) GLBXF.O 0.30 (0.00 | 0.00%) QMX.T 0.100 (-0.005 | -4.76%) BKM.V 3.50 (-0.18 | -4.89%) PBM 3.50 (+0.05 | +1.45%) ISR 0.57 (0.00 | 0.00%) XTC.T 5.90 (+0.01 | +0.17%) TVE.V 2.05 (-0.01 | -0.49%)

Bioniche Life Sciences Inc.

BNC.T (TSX)
$0.34aaa
Change +0.02 +6.25%
Volume 38,025
52 week Low Hi
  $0.18 $0.69
Financial Information
Shares Outstanding: 104,523,477
(As per the latest financial statements)
Fully Diluted Shares: 111,153,718
(As per the latest financial statements)
Est. Market Float: -
Market Cap.: $35,537,982
Last Declared Dividend: -
EPS last 3 months : $(0.05)
EPS Trailing 12 months: $(0.26)
Long-Term Debt: $27,142,000
Financial Year-End: Jun 30
Updated: 2013-06-19 12:40
15-20 minutes delay

Renmark Financial Disclaimer

The information contained above was approved by the company presented and is reproduced with its authorization or was estimated using the latest publicly disclosed information. The accuracy and completeness of that information are the sole responsibility of the said company.

This document is published for general information only and it should not be interpreted as an investment recommendation nor an offer or a solicitation to buy or sell securities issued by the said company. Renmark does not and will not accept any responsibility or liability for investment decisions made on the basis of the information herein contained.

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary and innovative products for human and animal health markets worldwide. The fully-integrated company employs more than 200 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop and commercialize products that advance human or animal health and increase shareholder value.

Graeme McRae - President & Chief Executive Officer

Cindy Benning - Senior Vice-President, Operations, Quality & Regulatory Affairs

Debi Butler - Corporate Controller

Monique Champagne - Vice-President, Clinical Research

Rick Culbert - President, Bioniche Food Safety

Mohamed Elrafih - Vice-President, Manufacturing Operations

Brian Ford - Chief Financial Officer

Andrew Grant - President, Bioniche Animal Health (global)

Bruce McLeod - Vice-President, Human Resources

Mairi Phillips - Director, Legal Services & Corporate Secretary

Jennifer Shea - Vice-President, Communications, Investor & Government Relations

Michael Rubin - Vice-President, Business Development

James Rae - Independent Chairman

Graeme McRae - Director

Dr. Stan Alkemade - Director

Dr. Armen Aprikian (Observer) - Director

Albert Beraldo - Director

Rod Budd - Director

Margaret Cunningham - Director

Dr. James Johnson - Director

The Hon. Lyle Vanclief - Director

Headquarters:

231 Dundas Street East
Belleville, Ontario
K8N 1E2 Canada

Telephone: (613) 966-8058
Fax: (613) 966-4177

For additional info., contact
Bettina Filippone
Christine Stewart

Montréal

Telephone: (514) 939-3989
Fax: (514) 939-3717

Toronto

Telephone: (416) 644-2020
Fax: (416) 644-2021
Home Bioniche Life Sciences Inc.